{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:20:07Z","timestamp":1782606007100,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29822-5","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:36:18Z","timestamp":1764243378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of toxicity and mechanisms of aspartame in kidney stones with network toxicology and molecular docking strategy"],"prefix":"10.1038","volume":"15","author":[{"given":"Kailiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"29822_CR1","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3390\/nu13061957","volume":"13","author":"K Czarnecka","year":"2021","unstructured":"Czarnecka, K. et al. Aspartame-true or false? Narrative review of safety analysis of general use in products. Nutrients 13, 1957. https:\/\/doi.org\/10.3390\/nu13061957 (2021).","journal-title":"Nutrients"},{"key":"29822_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/10408440701516184","volume":"37","author":"BA Magnuson","year":"2007","unstructured":"Magnuson, B. A. et al. Aspartame: A safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit. Rev. Toxicol. 37, 629\u2013727 (2007).","journal-title":"Crit. Rev. Toxicol."},{"key":"29822_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031570","volume":"7","author":"KS Collison","year":"2012","unstructured":"Collison, K. S. et al. Gender dimorphism in aspartame-induced impairment of spatial cognition and insulin sensitivity. PLoS ONE 7, e31570 (2012).","journal-title":"PLoS ONE"},{"key":"29822_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109841","volume":"9","author":"MS Palmnas","year":"2014","unstructured":"Palmnas, M. S. et al. Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PLoS ONE 9, e109841 (2014).","journal-title":"PLoS ONE"},{"key":"29822_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12958-023-01115-4","volume":"21","author":"AQ Naik","year":"2023","unstructured":"Naik, A. Q., Zafar, T. & Shrivastava, V. K. The impact of non-caloric artificial sweetener aspartame on female reproductive system in mice model. Reprod. Biol. Endocrinol. 21, 73 (2023).","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"Suppl1","key":"29822_CR6","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.freeradbiomed.2014.10.759","volume":"75","author":"I Finamor","year":"2014","unstructured":"Finamor, I. et al. N-Acetylcysteine protects the rat kidney against aspartame-induced oxidative stress. Free. Radic. Biol. Med. 75(Suppl1), S30 (2014).","journal-title":"Free. Radic. Biol. Med."},{"key":"29822_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s13197-024-06077-y","volume":"62","author":"H Sharma","year":"2025","unstructured":"Sharma, H., Hilal, A., Aseri, G. K. & Jain, N. Sweet or sour? A Review of the aspartame market landscape, carcinogenicity, and its socioeconomic Impact. J. Food Sci. Technol. Mysore 62, 24\u201337 (2025).","journal-title":"J. Food Sci. Technol. Mysore"},{"key":"29822_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/01480545.2012.658403","volume":"36","author":"M Abhilash","year":"2013","unstructured":"Abhilash, M., Sauganth, P. M., Varghese, M. V. & Nair, R. H. Long-term consumption of aspartame and brain antioxidant defense status. Drug. Chem. Toxicol. 36, 135\u2013140 (2013).","journal-title":"Drug. Chem. Toxicol."},{"key":"29822_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12967-024-06047-0","volume":"23","author":"J Xie","year":"2025","unstructured":"Xie, J. et al. An integrative analysis reveals cancer risk associated with artificial sweeteners. J. Transl. Med. 23, 32 (2025).","journal-title":"J. Transl. Med."},{"key":"29822_CR10","doi-asserted-by":"publisher","first-page":"1387676","DOI":"10.3389\/fnut.2024.1387676","volume":"11","author":"Z Ran","year":"2024","unstructured":"Ran, Z. et al. Linking artificial sweetener intake with kidney function: Insights from NHANES 2003\u20132006 and findings from mendelian randomization research. Front. Nutr. 11, 1387676 (2024).","journal-title":"Front. Nutr."},{"key":"29822_CR11","doi-asserted-by":"publisher","first-page":"1159616","DOI":"10.3389\/fmed.2023.1159616","volume":"10","author":"T Chen","year":"2023","unstructured":"Chen, T. et al. Oxalate as a potent promoter of kidney stone formation. Front. Med. 10, 1159616 (2023).","journal-title":"Front. Med."},{"key":"29822_CR12","first-page":"333","volume":"45","author":"R Kachkoul","year":"2023","unstructured":"Kachkoul, R. et al. Urolithiasis: History, epidemiology, aetiologic factors and management. Malays. J. Pathol. 45, 333\u2013352 (2023).","journal-title":"Malays. J. Pathol."},{"key":"29822_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/healthcare11030424","volume":"11","author":"K Stamatelou","year":"2023","unstructured":"Stamatelou, K. & Goldfarb, D. S. Epidemiology of kidney stones. Healthcare (Basel). 11, 424. https:\/\/doi.org\/10.3390\/healthcare11030424 (2023).","journal-title":"Healthcare."},{"key":"29822_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.urology.2019.04.012","volume":"129","author":"JB Ward","year":"2019","unstructured":"Ward, J. B. et al. Pediatric urinary stone disease in the United States: The urologic diseases in America project. Urology 129, 180\u2013187 (2019).","journal-title":"Urology"},{"key":"29822_CR15","first-page":"e86","volume":"12","author":"V Romero","year":"2010","unstructured":"Romero, V., Akpinar, H. & Assimos, D. G. Kidney stones: A global picture of prevalence, incidence, and associated risk factors. Rev. Urol. 12, e86\u2013e96 (2010).","journal-title":"Rev. Urol."},{"key":"29822_CR16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.juro.2017.03.124","volume":"198","author":"PM Ferraro","year":"2017","unstructured":"Ferraro, P. M., Taylor, E. N., Gambaro, G. & Curhan, G. C. Dietary and lifestyle risk factors associated with incident kidney stones in men and women. J. Urol. 198, 858\u2013863 (2017).","journal-title":"J. Urol."},{"key":"29822_CR17","doi-asserted-by":"publisher","first-page":"17001","DOI":"10.1038\/nrdp.2017.1","volume":"3","author":"SR Khan","year":"2017","unstructured":"Khan, S. R. et al. Kidney stones. Nat. Rev. Dis. Primers 3, 17001 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"29822_CR18","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1080\/10408398.2024.2411410","volume":"65","author":"Q Liu","year":"2024","unstructured":"Liu, Q. et al. Deciphering the multifaceted effects of artificial sweeteners on body health and metabolic functions: A comprehensive review and future perspectives. Crit. Rev. Food. Sci. Nutr. 65, 5394\u20135416 (2024).","journal-title":"Crit. Rev. Food. Sci. Nutr."},{"key":"29822_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2024.142711","volume":"363","author":"J He","year":"2024","unstructured":"He, J., Zhu, X., Xu, K., Li, Y. & Zhou, J. Network toxicological and molecular docking to investigate the mechanisms of toxicity of agricultural chemical thiabendazole. Chemosphere 363, 142711 (2024).","journal-title":"Chemosphere"},{"key":"29822_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119480","volume":"343","author":"X Li","year":"2025","unstructured":"Li, X. et al. Application and development trends of network toxicology in the safety assessment of traditional Chinese medicine. J. Ethnopharmacol. 343, 119480 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"29822_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"XY Meng","year":"2011","unstructured":"Meng, X. Y., Zhang, H. X., Mezei, M. & Cui, M. Molecular docking: A powerful approach for structure-based drug discovery. Curr. Comput. Aided Drug Des. 7, 146\u2013157 (2011).","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"29822_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. Kegg: Biological systems database as a model of the real world. Nucleic. Acids. Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic. Acids. Res."},{"key":"29822_CR23","first-page":"8","volume":"8","author":"GM Morris","year":"2008","unstructured":"Morris, G. M., Huey, R. & Olson, A. J. Using autodock for ligand-receptor docking. Curr. Protoc. Bioinform. 8, 8\u201314 (2008).","journal-title":"Curr. Protoc. Bioinform."},{"key":"29822_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.167904","volume":"905","author":"S Huang","year":"2023","unstructured":"Huang, S. Efficient analysis of toxicity and mechanisms of environmental pollutants with network toxicology and molecular docking strategy: Acetyl tributyl citrate as an example. Sci. Total Environ. 905, 167904 (2023).","journal-title":"Sci. Total Environ."},{"key":"29822_CR25","doi-asserted-by":"publisher","first-page":"11492","DOI":"10.1038\/s41598-024-62461-w","volume":"14","author":"D Chen","year":"2024","unstructured":"Chen, D. & Hou, X. Aspartame carcinogenic potential revealed through network toxicology and molecular docking insights. Sci. Rep. 14, 11492 (2024).","journal-title":"Sci. Rep."},{"key":"29822_CR26","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3945\/ajcn.111.030833","volume":"96","author":"ES Schernhammer","year":"2012","unstructured":"Schernhammer, E. S. et al. Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am. J. Clin. Nutr. 96, 1419\u20131428 (2012).","journal-title":"Am. J. Clin. Nutr."},{"key":"29822_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuro.2024.03.004","volume":"102","author":"H Ma","year":"2024","unstructured":"Ma, H., Deng, J., Liu, J., Jin, X. & Yang, J. Daytime aspartame intake results in larger influences on body weight, serum corticosterone level, serum\/cerebral cytokines levels and depressive-like behaviors in mice than nighttime intake. Neurotoxicology 102, 37\u201347 (2024).","journal-title":"Neurotoxicology"},{"key":"29822_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jocn.2018.06.043","volume":"56","author":"AK Choudhary","year":"2018","unstructured":"Choudhary, A. K. & Lee, Y. Y. The debate over neurotransmitter interaction in aspartame usage. J. Clin. Neurosci. 56, 7\u201315 (2018).","journal-title":"J. Clin. Neurosci."},{"key":"29822_CR29","first-page":"339","volume":"11","author":"MR Ardalan","year":"2017","unstructured":"Ardalan, M. R., Tabibi, H., Ebrahimzadeh, A. V. & Malek, M. A. Nephrotoxic effect of aspartame as an artificial sweetener: A brief review. Iran. J. Kidney Dis. 11, 339\u2013343 (2017).","journal-title":"Iran. J. Kidney Dis."},{"key":"29822_CR30","doi-asserted-by":"publisher","first-page":"1226082","DOI":"10.3389\/fnut.2023.1226082","volume":"10","author":"S Yin","year":"2023","unstructured":"Yin, S. et al. Association between added sugars and kidney stones in U.S. adults: Data from national health and nutrition examination survey 2007\u20132008. Front. Nutr. 10, 1226082 (2023).","journal-title":"Front. Nutr."},{"key":"29822_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5114\/fn.2013.34191","volume":"51","author":"K Rycerz","year":"2013","unstructured":"Rycerz, K. & Jaworska-Adamu, J. E. Effects of aspartame metabolites on astrocytes and neurons. Folia Neuropathol. 51, 10\u201317 (2013).","journal-title":"Folia Neuropathol."},{"key":"29822_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2025.109125","volume":"145","author":"A van Wegberg","year":"2025","unstructured":"van Wegberg, A. et al. European guidelines on diagnosis and treatment of phenylketonuria: First revision. Mol. Genet. Metab. 145, 109125 (2025).","journal-title":"Mol. Genet. Metab."},{"key":"29822_CR33","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.3390\/nu12123600","volume":"12","author":"AL Maghiari","year":"2020","unstructured":"Maghiari, A. L. et al. High concentrations of aspartame induce pro-angiogenic effects in ovo and cytotoxic effects in Ht-29 human colorectal carcinoma cells. Nutrients 12, 3600. https:\/\/doi.org\/10.3390\/nu12123600 (2020).","journal-title":"Nutrients"},{"key":"29822_CR34","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.humpath.2013.07.032","volume":"44","author":"X Zhu","year":"2013","unstructured":"Zhu, X. et al. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin a nephropathy\/membranous nephropathy. Hum. Pathol. 44, 2806\u20132813 (2013).","journal-title":"Hum. Pathol."},{"key":"29822_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000324521","volume":"34","author":"G Wang","year":"2011","unstructured":"Wang, G. et al. Expression of ace and Ace2 in patients with hypertensive nephrosclerosis. Kidney Blood Press. Res. 34, 141\u2013149 (2011).","journal-title":"Kidney Blood Press. Res."},{"key":"29822_CR36","doi-asserted-by":"publisher","first-page":"2382503","DOI":"10.1080\/15384047.2024.2382503","volume":"25","author":"FS Alves-Hanna","year":"2024","unstructured":"Alves-Hanna, F. S. et al. Association between the Il1B-511 C>T polymorphism and the risk of hematologic malignancies: Data from a meta-analysis. Cancer Biol. Ther. 25, 2382503 (2024).","journal-title":"Cancer Biol. Ther."},{"key":"29822_CR37","doi-asserted-by":"publisher","first-page":"3068365","DOI":"10.1155\/2018\/3068365","volume":"2018","author":"T Alelign","year":"2018","unstructured":"Alelign, T. & Petros, B. Kidney stone disease: An update on current concepts. Adv. Urol. 2018, 3068365 (2018).","journal-title":"Adv. Urol."},{"key":"29822_CR38","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.ekir.2023.01.017","volume":"8","author":"S Jorge","year":"2023","unstructured":"Jorge, S. et al. Bi-allelic ren mutations and undetectable plasma renin activity in a patient with progressive Ckd. Kidney Int. Rep. 8, 1112\u20131116 (2023).","journal-title":"Kidney Int. Rep."},{"key":"29822_CR39","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.kint.2020.06.041","volume":"98","author":"M Zivna","year":"2020","unstructured":"Zivna, M. et al. An international cohort study of autosomal dominant tubulointerstitial kidney disease due to ren mutations identifies distinct clinical subtypes. Kidney Int. 98, 1589\u20131604 (2020).","journal-title":"Kidney Int."},{"key":"29822_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-015-0217-0","volume":"23","author":"G Ramanathan","year":"2016","unstructured":"Ramanathan, G., Elumalai, R., Periyasamy, S. & Lakkakula, B. V. Renin gene Rs1464816 polymorphism contributes to chronic kidney disease progression in Adpkd. J. Biomed. Sci. 23, 1 (2016).","journal-title":"J. Biomed. Sci."},{"key":"29822_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1517\/14656566.2013.775250","volume":"14","author":"H Xu","year":"2013","unstructured":"Xu, H., Zisman, A. L., Coe, F. L. & Worcester, E. M. Kidney stones: An update on current pharmacological management and future directions. Expert Opin. Pharmacother. 14, 435\u2013447 (2013).","journal-title":"Expert Opin. Pharmacother."},{"key":"29822_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13018-024-04628-9","volume":"19","author":"H Lv","year":"2024","unstructured":"Lv, H., Liu, P., Hu, H., Li, X. & Li, P. Mir-98-5P plays suppressive effects on Il-1beta-induced chondrocyte injury associated with osteoarthritis by targeting Casp3. J. Orthop. Surg. Res. 19, 239 (2024).","journal-title":"J. Orthop. Surg. Res."},{"key":"29822_CR43","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1038\/s41598-020-60614-1","volume":"10","author":"BX Li","year":"2020","unstructured":"Li, B. X. et al. Novel pathways of Hiv latency reactivation revealed by integrated analysis of transcriptome and target profile of bryostatin. Sci. Rep. 10, 3511 (2020).","journal-title":"Sci. Rep."},{"key":"29822_CR44","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1172\/JCI67951","volume":"123","author":"YF Lin","year":"2013","unstructured":"Lin, Y. F. et al. Targeting the Xiap\/caspase-7 complex selectively kills caspase-3-deficient malignancies. J. Clin. Invest. 123, 3861\u20133875 (2013).","journal-title":"J. Clin. Invest."},{"key":"29822_CR45","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/genes13060943","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Genetic variants involved in the crystallization pathway are associated with calcium nephrolithiasis in the Chinese Han population. Genes\u00a0(Basel). 13, 943.\u00a0https:\/\/doi.org\/10.3390\/genes13060943 (2022).","journal-title":"Genes"},{"key":"29822_CR46","doi-asserted-by":"publisher","first-page":"2416825","DOI":"10.1080\/13510002.2024.2416825","volume":"29","author":"X Su","year":"2024","unstructured":"Su, X. et al. Selenium participates in the formation of kidney stones by alleviating endoplasmic reticulum stress and apoptosis of renal tubular epithelial cells. Redox Rep. 29, 2416825 (2024).","journal-title":"Redox Rep."},{"key":"29822_CR47","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/2211-5463.13384","volume":"12","author":"X Solone","year":"2022","unstructured":"Solone, X. et al. Map kinases differentially bind and phosphorylate Nos3 via two unique Nos3 sites. FEBS Open Bio 12, 1075\u20131086 (2022).","journal-title":"FEBS Open Bio"},{"key":"29822_CR48","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s11255-023-03463-x","volume":"55","author":"R Tan","year":"2023","unstructured":"Tan, R., Rao, N. N., Horwood, C. M., Passaris, G. & Juneja, R. Recurrent nephrolithiasis and loss of kidney function: A cohort study. Int. Urol. Nephrol. 55, 1539\u20131547 (2023).","journal-title":"Int. Urol. Nephrol."},{"key":"29822_CR49","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3109\/0886022X.2014.900601","volume":"36","author":"Z Yun","year":"2014","unstructured":"Yun, Z. et al. Association of endothelial nitric oxide synthase gene polymorphisms with end-stage renal disease: A systematic review and meta-analysis. Ren. Fail. 36, 987\u2013993 (2014).","journal-title":"Ren. Fail."},{"key":"29822_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00240-018-1094-2","volume":"47","author":"R Palsson","year":"2019","unstructured":"Palsson, R., Indridason, O. S., Edvardsson, V. O. & Oddsson, A. Genetics of common complex kidney stone disease: Insights from genome-wide association studies. Urolithiasis 47, 11\u201321 (2019).","journal-title":"Urolithiasis"},{"key":"29822_CR51","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1210\/clinem\/dgaa123","volume":"105","author":"O Bayomy","year":"2020","unstructured":"Bayomy, O., Zaheer, S., Williams, J. S., Curhan, G. & Vaidya, A. Disentangling the relationships between the renin\u2013angiotensin-aldosterone system, calcium physiology, and risk for kidney stones. J. Clin. Endocrinol. Metab. 105, 1937\u20131946 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"29822_CR52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ajh\/hpaa044","volume":"33","author":"LG Sanchez-Lozada","year":"2020","unstructured":"Sanchez-Lozada, L. G. et al. Uric acid and hypertension: An update with recommendations. Am. J. Hypertens. 33, 583\u2013594 (2020).","journal-title":"Am. J. Hypertens."},{"key":"29822_CR53","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/iub.2250","volume":"72","author":"Y Sun","year":"2020","unstructured":"Sun, Y. et al. Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of Tlr4\/Nf-Kappab and Nlrp3 inflammasome. IUBMB Life 72, 1065\u20131074 (2020).","journal-title":"IUBMB Life"},{"key":"29822_CR54","doi-asserted-by":"publisher","first-page":"6428498","DOI":"10.1155\/2020\/6428498","volume":"2020","author":"Z Yifan","year":"2020","unstructured":"Yifan, Z. et al. Ceftriaxone calcium crystals induce acute kidney injury by Nlrp3-mediated inflammation and oxidative stress injury. Oxidative Med. Cell. Longev. 2020, 6428498 (2020).","journal-title":"Oxidative Med. Cell. Longev."},{"key":"29822_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153562","volume":"86","author":"T Ding","year":"2021","unstructured":"Ding, T. et al. Vitexin exerts protective effects against calcium oxalate crystal-induced kidney pyroptosis in vivo and in vitro. Phytomedicine 86, 153562 (2021).","journal-title":"Phytomedicine"},{"key":"29822_CR56","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/bju.16454","volume":"134","author":"B Su","year":"2024","unstructured":"Su, B., Ren, Y., Yao, W., Su, Y. & He, Q. Mitochondrial dysfunction and Nlrp3 inflammasome: Key players in kidney stone formation. Bju Int. 134, 696\u2013713 (2024).","journal-title":"Bju Int."},{"key":"29822_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.818625","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Role of Ros-induced Nlrp3 inflammasome activation in the formation of calcium oxalate nephrolithiasis. Front. Immunol. 13, 818625 (2022).","journal-title":"Front. Immunol."},{"key":"29822_CR58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/1472-6882-13-228","volume":"13","author":"W Zhai","year":"2013","unstructured":"Zhai, W. et al. Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in Nrk-52E cells and the ethylene glycol induced renal stone formation in rat. Bmc Complement. Altern. Med. 13, 228 (2013).","journal-title":"Bmc Complement. Altern. Med."},{"key":"29822_CR59","doi-asserted-by":"publisher","first-page":"1011102","DOI":"10.3389\/fmicb.2022.1011102","volume":"13","author":"JA Chmiel","year":"2022","unstructured":"Chmiel, J. A. et al. New perspectives on an old grouping: The genomic and phenotypic variability of oxalobacter formigenes and the implications for calcium oxalate stone prevention. Front. Microbiol. 13, 1011102 (2022).","journal-title":"Front. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29822-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:02:44Z","timestamp":1777136564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29822-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["29822"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29822-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45563"}}